These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Viral hepatitis and blood transfusion]. Larsen J; Hetland G; Skaug K; Maeland A Tidsskr Nor Laegeforen; 1991 Mar; 111(7):825-8. PubMed ID: 1850559 [TBL] [Abstract][Full Text] [Related]
7. [Post-transfusion hepatitis: the point of view of the infectious disease specialist]. Giusti G; Galanti B Ric Clin Lab; 1984; 14 Suppl 1():3-16. PubMed ID: 6429829 [No Abstract] [Full Text] [Related]
8. Post-transfusion hepatitis and serum alanine aminotransferase in blood donors. N Engl J Med; 1981 Aug; 305(7):403-4. PubMed ID: 6789203 [No Abstract] [Full Text] [Related]
9. Hepatitis B viral markers in surface antigen negative blood donors: the need to look beyond antibody negativity. Salawu L; Adegoke AO; Aboderin AO; Huraina HA West Afr J Med; 2011; 30(4):292-5. PubMed ID: 22669836 [TBL] [Abstract][Full Text] [Related]
10. [Presence of Australia antigen in blood donors]. Gota F Arch Sci Med (Torino); 1980; 137(2):217-20. PubMed ID: 7224843 [TBL] [Abstract][Full Text] [Related]
11. Prevention of posttransfusion hepatitis B and C by screening for antibody to hepatitis C virus and antibody to HBcAg. Chung HT; Lee JS; Lok AS Hepatology; 1993 Nov; 18(5):1045-9. PubMed ID: 7693569 [TBL] [Abstract][Full Text] [Related]
13. The clinical problem of hepatitis transmission; Barker LF; Gerety RJ Prog Clin Biol Res; 1976; 11():163-82. PubMed ID: 799307 [TBL] [Abstract][Full Text] [Related]
14. Current issues in blood component therapy: transmission of infectious diseases. Menitove JE Oncology (Williston Park); 1987 Jun; 1(4):21-30. PubMed ID: 2856350 [TBL] [Abstract][Full Text] [Related]
15. Prospective assessment of donor blood screening for antibody to hepatitis C virus and high-titer antibody to HBcAg as a means of preventing posttransfusion hepatitis. Takano S; Omata M; Ohto M; Satomura Y Hepatology; 1993 Aug; 18(2):235-9. PubMed ID: 8393422 [TBL] [Abstract][Full Text] [Related]
16. Posttransfusion hepatitis: a persistent problem. Ramirez AM; Woodfield DG N Z Med J; 1987 Oct; 100(834):649-51. PubMed ID: 3132660 [TBL] [Abstract][Full Text] [Related]
17. Current status of posttransfusion hepatitis. Alter HJ; Holland PV; Purcell RH Pathobiol Annu; 1980; 10():135-56. PubMed ID: 6777742 [No Abstract] [Full Text] [Related]
18. Hepatitis after the transfusion of frozen red cells and washed red cells. Haugen RK N Engl J Med; 1979 Aug; 301(8):393-5. PubMed ID: 460339 [TBL] [Abstract][Full Text] [Related]
19. [Currently available means for the prevention of post-transfusion hepatitis and criteria for their application]. Bedarida G; Cambiè G; D'Agostino F; Sterza G Ric Clin Lab; 1984; 14 Suppl 1():37-60. PubMed ID: 6429830 [No Abstract] [Full Text] [Related]
20. [Antibodies to hepatitis B core antigen in blood donors and hepatitis non-A, non-B in blood recipients]. Sugg U Beitr Infusionsther; 1988; 21():177-81. PubMed ID: 2462972 [No Abstract] [Full Text] [Related] [Next] [New Search]